Oral Vitamin K—US Newborns Need an FDA-Approved Option

Key Points

• Evaluate the increasing refusal of vitamin K shots for newborns and the need for an FDA-approved oral alternative.
• Analyze trends in parental decisions regarding vitamin K prophylaxis.
• Discuss the implications of these trends for newborn health.
• Recommend the formulation of an FDA-approved oral vitamin K product.
• Increased rates of parental decline in vitamin K shots for newborns.
• The need for convenient alternatives like oral vitamin K is highlighted.
• Oral formulations may improve compliance and protect newborns from vitamin K deficiency.